CLINICAL_TRIALS
trial_result
· 2018-07-17
Clinical Trial Update: Eslicarbazepine Acetate Monotherapy Long Term Study [Phase 3]
Summary
A Phase 3 long-term monotherapy trial of eslicarbazepine acetate in epilepsy has completed, with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sumitomo Pharma America, Inc. | Conditions: Epilepsy | Phase 3 | Status: COMPLETED | Results posted: 2018-07-17